The system is designed to provide a triple impact: clinical benefits for patients, better visualization and control for surgeons, and increased efficiency for hospitals
The Levita robotic platform is designed to realize the clinical advantages of the company's first commercial product, the Levita Magnetic Surgery System, including reducing patient pain, speeding up recovery, and reducing scars. (Photo: Business Wire)
The Levita robotic platform is designed to realize the clinical advantages of the company's first commercial product, the Levita Magnetic Surgery System, including reducing patient pain, speeding up recovery, and reducing scars. (Photo: Business Wire)
Menlo Park, Calif.--(BUSINESS WIRE)--Levita Magnetics, a company whose mission is to improve more patients and get better surgical opportunities, today announced that it has used the company’s latest system to perform The first robot-assisted surgery Levita® robot platform under development. The first case was a reduced incision laparoscopic cholecystectomy (cholecystectomy) performed by Dr. Ignacio Robles, a minimally invasive surgeon at the San Diego Clinic INDISA, which is part of the current clinical research on the system in Chile.
The new robotic platform aims to provide the clinical advantages of the company's first commercial product, the Levita® magnetic surgical system, including reduced patient pain, faster recovery and fewer scars. 1,2 The platform aims to improve visualization, maintain surgeon control instruments, and improve hospital efficiency by reducing the auxiliary staff required to perform procedures. The robot platform occupies a small area and is designed for large-volume outpatient clinics or same-day discharge abdominal surgery. The purpose of these comprehensive advantages is to increase the volume of high-quality and efficient operations, while improving the surgical opportunities for patients.
“I’m very happy to have the opportunity to use this innovative robotic platform to perform the world’s first procedure. The first operation was a challenging acute cholecystitis. Nevertheless, the procedure was very smooth and the patient recovered well, 30 days after surgery. Complication report. Since then, we have performed two more acute cholecystectomy using the robotic platform, and two patients were enrolled and treated on the same day," said Dr. Robles. "Combining Levita's magnetic technology with a robotic platform shows great promise for improving surgeons' control and efficiency during surgery. I am very pleased to continue participating in this clinical research to further support the development of this platform."
"It is reported that Levita's original magnetic surgical system can improve patients' surgical results, reduce pain and reduce incisions," said Steven D. Schwaitzberg, professor and professor of the Department of Surgery at the Jacobs School of Medicine and Biomedical Sciences and FACS MD. University of Buffalo. "Further advance this technology to the robotic surgery platform. By providing a stable visualization platform without the need for additional assistants, it is possible to play a role in many operations."
"We are taking magnetic surgery technology to a new level through this disruptive approach. Our robotic platform is designed to be the first to achieve the clinical benefits of minimally invasive surgery with fewer incisions, while allowing surgeons to fully control the platform and direct Surgical instruments next to the patient," said Dr. Alberto Rodriguez-Navarro, a minimally invasive surgeon and founder and CEO of Levita Magnetics. "We believe that timely access to the required surgery has a direct impact on the quality of life of patients and may reduce the risk of complications or death due to underlying diseases. Our ultimate goal is to improve the capabilities of surgeons and hospitals worldwide , To provide more patients with better surgical opportunities in their communities. We are advancing our clinical research and plan to submit the Levita robotic platform to the US FDA for approval by the end of 2021. Our goal is to achieve society Expectations for surgical robots."
About Levita® Robotic Platform Levita Robotic Platform is a research system. It cannot be sold commercially in the United States and has not been approved by the Food and Drug Administration (FDA).
About the Levita® Magnetic Surgery System The Levita Magnetic Surgery System supports port-reduction laparoscopic surgery procedures and is designed to minimize the surgical footprint. The system consists of an external magnet placed on the skin, which controls a shaftless detachable gripper, allowing the instrument to move without being restricted by a fixed position pivot point. The Levita magnetic surgical system is suitable for grasping and retracting the body and the bottom of the gallbladder during laparoscopic cholecystectomy in the United States; the liver during bariatric surgery; the prostate and surrounding tissues during prostatectomy; and the colorectal and colorectal surrounding tissues. During colorectal surgery, to facilitate access and visualization of the surgical site. The device is suitable for patients with a body mass index (BMI) ranging from 20 to 60 kg/m2.
About Levita® Magnetics Levita Magnetics, headquartered in Silicon Valley, has developed the first and only Magnetic Surgery® platform, the Levita Magnetic Surgical System. This proprietary technology was founded by the innovator and surgeon, Dr. Alberto Rodriguez-Navarro, to develop minimally invasive surgery, with the goal of minimizing the surgical footprint and improving patient prognosis. It is the first magnetic surgical system approved by the FDA. For more information, please visit www.magneticsurgery.com and www.levita.com.
1. Wales LK et al. Compared with the Nathanson device, magnetic liver traction can reduce postoperative pain and hospital stay in bariatric surgery. J Laparoendosc Adv Surg Tech A. 2021 31(2):194-202 2. Rivas H et al. Magnetic surgery: results of the first prospective clinical trial in 50 patients. Annals of Surgery, 2018,267(1):88-93.
Sierra Smith Health Commerce sierra@healthandcommerce.com (408) 540-4296
The first robot-assisted surgery was performed using the Levita® robotic platform, a new product developed by Levita Magnetics.
Sierra Smith Health Commerce sierra@healthandcommerce.com (408) 540-4296